Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
March 22, 2024 07:00 ET
|
Pharmazz, Inc.
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin®) as a resuscitative agent
Capsule and Retia Medical Collaborate on Argos Cardiac Monitor to Streamline Device Interoperability, Protect Patient Safety
January 05, 2021 09:00 ET
|
Retia Medical, LLC
ANDOVER, Mass. and VALHALLA, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Retia Medical is the first company to utilize Capsule Technologies’ new Device Driver Interface (DDI) development strategy to...
Retia Medical Receives Purchase Orders From Three of the Top Five Hospitals in the United States
October 30, 2019 15:45 ET
|
Retia Medical, LLC
VALHALLA, N.Y., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Retia Medical, LLC announced today that three of the top five U.S. hospitals completed a purchase of a large number of Argos Hemodynamic Monitors....